Document is current
Any future updates will be listed below
-
Authors
Selvaraj, Emmanuel A.
Ba-Ssalamah, Ahmed
Poetter-Lang, Sarah
Paun, Bruno
Ridgway, Gerard R.
Beyer, Cayden
Andersson, Anneli
Brady, Sir Michael
Pansini, Michele
Culver, Emma L.
Bailey, Adam
DPhil, Michael Pavlides
- License Information
-
More Information
Article History
Received: 25 November 2025
Accepted: 17 February 2026
First Online: 4 March 2026
Declarations
:
: The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and the principles of good clinical practice. All participants provided written informed consent. Ethical approval was granted by the National Research Ethics Service, and by the local Research and Development Department at Oxford University Hospitals National Health Service Foundation Trust.
: Not applicable.
: M.Pav. M.B. and G.R. are shareholders in Perspectum Ltd. B.P., C.B., A.A. and M.Pans. are employees of Perspectum Ltd. A.B.S. receives consulting fees from Bayer and honoraria for lectures from Novartis, Siemens, Bayer, and Sanofi. E.A.S., A.B., S.P.L. and E.L.C. have no competing interests to declare.
